SCHEMBL5817995

SCHEMBL5817995

COc1cc(-c2nn(C3CCNCC3)c3ccnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 12/20 0.64
SRC P12931 6/20 0.64
TEK Q02763 4/20 0.64
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
FYN P06241 2/20 0.49
TP53 P04637 2/20 0.49
PLK4 O00444 1/20 0.48
AURKA O14965 1/20 0.48
PAK4 O96013 1/20 0.48
CHEK2 O96017 1/20 0.48
ABL1 P00519 1/20 0.48
EGFR P00533 1/20 0.48
ERBB2 P04626 1/20 0.48
NTRK1 P04629 1/20 0.48
INSR P06213 1/20 0.48
CSF1R P07333 1/20 0.48
LYN P07948 1/20 0.48
HCK P08631 1/20 0.48
FGR P09769 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5823957 0.91 LCK (0.56) LCKSRCTEKFYNPLK4
SCHEMBL6278846 0.91 LCK (0.56) LCKSRCTEKFYNTP53
SCHEMBL4821436 0.89 LCK (0.80) LCKSRCTEKFYNPLK4
SCHEMBL5823810 0.85 SRC (0.49) LCKSRCTEKFYNPLK4
SCHEMBL6218794 0.82 LCK (0.69) LCKSRCTEKFYNPLK4
SCHEMBL5823953 0.81 LCK (0.69) LCKSRCTEKFYNPLK4
SCHEMBL6278841 0.81 LCK (0.69) LCKSRCTEKFYNPLK4
SCHEMBL5804828 0.81 LCK (0.68) LCKSRCTEKFYNPLK4
Acetic Acid SCHEMBL4828254 0.80 LCK (0.67) LCKSRCTEKFYNPLK4
SCHEMBL7050233 0.80 LCK (0.66) LCKSRCTEKFYNPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385524-A4 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2006-02-01 EP disclosed
EP-1385524-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS Abbott GmbH & Co. KG (DE) 2004-02-04 EP disclosed
WO-2002080926-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-17 WO disclosed